Over 30 years of executive pharma, biotech, cell therapy and healthcare experience
Corporate Officer in listed NYSE, NASDAQ, LSE, ASX and in other organisations for over 23-years
Expertise in COVID-19, GvHD, virology, I/O and cell & gene therapy
GSK, Sanofi-Synthélabo, Mesoblast and Benitec Biopharma
APAC based cross-border M&A and capital service principal with Eaton Square